365 related articles for article (PubMed ID: 27498362)
1. In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice.
Chadha P; Katare OP; Chhibber S
Microb Pathog; 2016 Oct; 99():68-77. PubMed ID: 27498362
[TBL] [Abstract][Full Text] [Related]
2. Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections.
Chadha P; Katare OP; Chhibber S
Burns; 2017 Nov; 43(7):1532-1543. PubMed ID: 28502784
[TBL] [Abstract][Full Text] [Related]
3. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice.
Kumari S; Harjai K; Chhibber S
J Microbiol Biotechnol; 2010 May; 20(5):935-41. PubMed ID: 20519918
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055.
Kumari S; Harjai K; Chhibber S
J Med Microbiol; 2011 Feb; 60(Pt 2):205-210. PubMed ID: 20965914
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products.
Kumari S; Harjai K; Chhibber S
J Infect Dev Ctries; 2010 Jun; 4(6):367-77. PubMed ID: 20601788
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of bacteriophage treatment in murine burn wound infection induced by klebsiella pneumoniae.
Kumari S; Harjai K; Chhibber S
J Microbiol Biotechnol; 2009 Jun; 19(6):622-8. PubMed ID: 19597322
[TBL] [Abstract][Full Text] [Related]
7. Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice.
Malik R; Chhibber S
J Microbiol Immunol Infect; 2009 Apr; 42(2):134-40. PubMed ID: 19597645
[TBL] [Abstract][Full Text] [Related]
8. Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice.
Chopra S; Harjai K; Chhibber S
Int J Med Microbiol; 2016 Dec; 306(8):707-716. PubMed ID: 27616281
[TBL] [Abstract][Full Text] [Related]
9. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model.
Anand T; Virmani N; Kumar S; Mohanty AK; Pavulraj S; Bera BC; Vaid RK; Ahlawat U; Tripathi BN
J Glob Antimicrob Resist; 2020 Jun; 21():34-41. PubMed ID: 31604128
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophage cocktail shows no toxicity and improves the survival of
Kelly L; Jameson E
J Virol; 2024 Jun; 98(6):e0027224. PubMed ID: 38771043
[No Abstract] [Full Text] [Related]
11. A method for generation phage cocktail with great therapeutic potential.
Gu J; Liu X; Li Y; Han W; Lei L; Yang Y; Zhao H; Gao Y; Song J; Lu R; Sun C; Feng X
PLoS One; 2012; 7(3):e31698. PubMed ID: 22396736
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae.
Feng Y; Fang Q; Luo H; Li J; Yin X; Zong Z
Int J Antimicrob Agents; 2024 Feb; 63(2):107088. PubMed ID: 38218324
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus.
Kifelew LG; Warner MS; Morales S; Vaughan L; Woodman R; Fitridge R; Mitchell JG; Speck P
BMC Microbiol; 2020 Jul; 20(1):204. PubMed ID: 32646376
[TBL] [Abstract][Full Text] [Related]
14. [Phage therapy for bacterial infection of burn].
Peng YZ; Huang GT
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):513-6. PubMed ID: 27647065
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.
Chhibber S; Kaur S; Kumari S
J Med Microbiol; 2008 Dec; 57(Pt 12):1508-1513. PubMed ID: 19018021
[TBL] [Abstract][Full Text] [Related]
17. Effective Topical Delivery of H-AgNPs for Eradication of Klebsiella pneumoniae-Induced Burn Wound Infection.
Chhibber S; Gondil VS; Singla L; Kumar M; Chhibber T; Sharma G; Sharma RK; Wangoo N; Katare OP
AAPS PharmSciTech; 2019 Apr; 20(5):169. PubMed ID: 31004249
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
Vinodkumar CS; Neelagund YF; Kalsurmath S
J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
[TBL] [Abstract][Full Text] [Related]
19. Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.
Regeimbal JM; Jacobs AC; Corey BW; Henry MS; Thompson MG; Pavlicek RL; Quinones J; Hannah RM; Ghebremedhin M; Crane NJ; Zurawski DV; Teneza-Mora NC; Biswas B; Hall ER
Antimicrob Agents Chemother; 2016 Oct; 60(10):5806-16. PubMed ID: 27431214
[TBL] [Abstract][Full Text] [Related]
20. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
